CN109965271A - A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN109965271A CN109965271A CN201910267322.5A CN201910267322A CN109965271A CN 109965271 A CN109965271 A CN 109965271A CN 201910267322 A CN201910267322 A CN 201910267322A CN 109965271 A CN109965271 A CN 109965271A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- vitamin
- children
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004556 brain Anatomy 0.000 title claims abstract description 64
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 57
- 230000035764 nutrition Effects 0.000 title claims abstract description 50
- 230000012010 growth Effects 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000009472 formulation Methods 0.000 title description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 28
- 229930003231 vitamin Natural products 0.000 claims abstract description 28
- 235000013343 vitamin Nutrition 0.000 claims abstract description 28
- 239000011782 vitamin Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000015097 nutrients Nutrition 0.000 claims abstract description 22
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 230000035622 drinking Effects 0.000 claims abstract description 18
- 235000008216 herbs Nutrition 0.000 claims abstract description 18
- 230000010354 integration Effects 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 17
- 239000004615 ingredient Substances 0.000 claims abstract description 16
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims description 125
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- 239000003921 oil Substances 0.000 claims description 25
- 235000019198 oils Nutrition 0.000 claims description 25
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 24
- 239000003094 microcapsule Substances 0.000 claims description 23
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 21
- 235000019197 fats Nutrition 0.000 claims description 20
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 18
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- 235000018102 proteins Nutrition 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 229920002774 Maltodextrin Polymers 0.000 claims description 14
- 239000005913 Maltodextrin Substances 0.000 claims description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000839 emulsion Substances 0.000 claims description 14
- 229940035034 maltodextrin Drugs 0.000 claims description 14
- 241000237502 Ostreidae Species 0.000 claims description 13
- 244000197580 Poria cocos Species 0.000 claims description 13
- 235000008599 Poria cocos Nutrition 0.000 claims description 13
- 229910052742 iron Inorganic materials 0.000 claims description 13
- 229960003284 iron Drugs 0.000 claims description 13
- 235000020636 oyster Nutrition 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 12
- 229960003080 taurine Drugs 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 12
- 229910052725 zinc Inorganic materials 0.000 claims description 12
- 235000016804 zinc Nutrition 0.000 claims description 12
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 10
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 10
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 10
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 10
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 10
- 108010073771 Soybean Proteins Proteins 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 10
- -1 carbon water Compound Chemical class 0.000 claims description 10
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 10
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims description 10
- 235000019710 soybean protein Nutrition 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229960005069 calcium Drugs 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 9
- 229960001231 choline Drugs 0.000 claims description 9
- 235000012054 meals Nutrition 0.000 claims description 9
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 8
- 239000011648 beta-carotene Substances 0.000 claims description 8
- 235000013734 beta-carotene Nutrition 0.000 claims description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 8
- 229960002747 betacarotene Drugs 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000010355 mannitol Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000001968 nicotinic acid Nutrition 0.000 claims description 8
- 229960003512 nicotinic acid Drugs 0.000 claims description 8
- 239000011664 nicotinic acid Substances 0.000 claims description 8
- 229940055726 pantothenic acid Drugs 0.000 claims description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims description 8
- 239000011713 pantothenic acid Substances 0.000 claims description 8
- 235000019155 vitamin A Nutrition 0.000 claims description 8
- 239000011719 vitamin A Substances 0.000 claims description 8
- 239000011715 vitamin B12 Substances 0.000 claims description 8
- 239000011716 vitamin B2 Substances 0.000 claims description 8
- 239000011647 vitamin D3 Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 229940045997 vitamin a Drugs 0.000 claims description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000011726 vitamin B6 Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 6
- 244000170916 Paeonia officinalis Species 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 229940114079 arachidonic acid Drugs 0.000 claims description 6
- 235000021342 arachidonic acid Nutrition 0.000 claims description 6
- 230000008901 benefit Effects 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 150000002270 gangliosides Chemical class 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 229940100688 oral solution Drugs 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000006041 probiotic Substances 0.000 claims description 6
- 235000018291 probiotics Nutrition 0.000 claims description 6
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 5
- 210000000988 bone and bone Anatomy 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims description 4
- 230000000529 probiotic effect Effects 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000036961 partial effect Effects 0.000 claims description 3
- 239000011435 rock Substances 0.000 claims description 3
- 241000606124 Bacteroides fragilis Species 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 240000003183 Manihot esculenta Species 0.000 claims description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 2
- 229920000294 Resistant starch Polymers 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 235000021254 resistant starch Nutrition 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 241000202807 Glycyrrhiza Species 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 238000011161 development Methods 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 8
- 235000005911 diet Nutrition 0.000 abstract description 7
- 230000037213 diet Effects 0.000 abstract description 7
- 230000029087 digestion Effects 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 230000001151 other effect Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 230000001256 tonic effect Effects 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 235000013350 formula milk Nutrition 0.000 description 22
- 230000000694 effects Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 230000018109 developmental process Effects 0.000 description 10
- 239000005862 Whey Substances 0.000 description 9
- 102000007544 Whey Proteins Human genes 0.000 description 9
- 108010046377 Whey Proteins Proteins 0.000 description 9
- 210000005036 nerve Anatomy 0.000 description 9
- 235000010469 Glycine max Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 230000004641 brain development Effects 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 235000010489 acacia gum Nutrition 0.000 description 6
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 210000004958 brain cell Anatomy 0.000 description 6
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 5
- 239000011162 core material Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 210000003754 fetus Anatomy 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000206575 Chondrus crispus Species 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 229960004373 acetylcholine Drugs 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 150000005672 tetraenes Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000143060 Americamysis bahia Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000001008 Dimocarpus longan Species 0.000 description 2
- 235000000235 Euphoria longan Nutrition 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- 108010083674 Myelin Proteins Proteins 0.000 description 2
- 102000006386 Myelin Proteins Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 240000002547 Rosa roxburghii Species 0.000 description 2
- 235000000640 Rosa roxburghii Nutrition 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000003132 food thickener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 210000005012 myelin Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000004248 oligodendroglia Anatomy 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 102100023995 Beta-nerve growth factor Human genes 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000555268 Dendroides Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000287826 Gallus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 239000000589 Siderophore Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000020243 first infant milk formula Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001905 globus pallidus Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960001227 oxiracetam Drugs 0.000 description 1
- IHLAQQPQKRMGSS-UHFFFAOYSA-N oxiracetam Chemical compound NC(=O)CN1CC(O)CC1=O IHLAQQPQKRMGSS-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000000862 serotonergic effect Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000033772 system development Effects 0.000 description 1
- 125000001990 thiamine group Chemical group 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a kind of children's brain growth tailored version clinical nutrition formulas comprising following component and its parts by weight: 15-35 parts of protein, 2~15 parts of fat, 40~60 parts of carbohydrate, 8-12 parts of dietary fibers, 0.2-1.2 parts of macroelements, 0.01-0.05 parts of microelements, 0.001-0.02 parts of liposoluble vitamins, 0.008-0.4 parts of water soluble vitamins, 4~8 parts of diet essence, 0.1-4 parts of integration of drinking and medicinal herbs ingredients and 0.05-2 parts of new resource foods;The invention further relates to the preparation methods of above-mentioned clinical nutrition formula.Pass through the screening and proportion of said components, the present invention is according to the design of the physilogical characteristics of pregnant woman and children, on the basis of guaranteeing protein, fat, carbohydrate, dietary fiber, supplement the macroelement and microelement of many needed by human body, and add the specific nutrients such as the integration of drinking and medicinal herbs ingredient with brain tonic and intelligence development, stomach strengthening and digestion promoting, strengthen immunity and other effects, new resource food, so that the formula nutritional is balanced, effectively guarantee children's brain growth, guarantee pregnant woman and infant's grows up healthy and sound in all respects.
Description
Technical field
The present invention relates to special medicine purposes formula food fields, and in particular to a kind of children's brain growth tailored version clinic battalion
Support formula and preparation method thereof.
Background technique
People in embryonic stage, as soon as by the continuous division growth of fertilized eggs, for brain cell, can division growth to more than 100 hundred million
A, this huge variation undoubtedly needs corresponding nutritional support.Newborn baby weight is about 370g~400g, only adult
Be the 50% of Adult Human Brain weight when 25%, six months, arrived child it is one-year-old when brain weight reached 900g, be equivalent to Adult Human Brain weight
60%~70%.After having arrived child two years old, although the growth rate of brain weight slows down, but the certain nerve cells of intracerebral, such as small
The intermediate nerve of type is former, exactly reaches maturity in this period of children.And the development of nerve cell axons and dendron, then may be used
To establish more intensive desmachyme in brain and spinal cord.At last virgin 12 years old or so, his brain weight substantially with adult
It is identical.It sees therefrom, whether brain development is normal, is determined by the quantity of cranial nerve cell and the density of desmachyme.Brain
Nerve cell number is more, then the IQ of children is possible to higher, and the compactness extent of desmachyme is also to determine children from now on
An important factor for intelligence height.From this, being the critical period of brain growth to 5 years old after children's birth, if child is in this period
Subalimentation can make child's brain that irreversible permanent sexual dysfunction occur.In conclusion trophic factor, environmental factor, education
Factor has a great impact to the development of the intelligence of children, and wherein trophic factor plays even more important effect.
The cerebral nervous system of fetus begins to develop on the the 5th, 6 week from pregnancy, until nerve channel healing completion in the 8th week, also
It is to say, after embryo nidation, nerve cell just starts to break up, and then generates various nerve cells movements in conjunction with cynapse, is cherishing
At pregnant 8th week, nerve channel just heals gradually, but the development of entire nervous system, can continue to that the pregnancy period terminates, or even go out to baby
After life in 3 years, it can just reach 97% maturation.Nervous system is in all organs, and period of expansion longest is also most already to open simultaneously
The organ of exhibition is originated, this is the well differentiated mankind and the maximum difference of other species.Due to currently on the market about brain
The nutrition product type of development is intricate, such as Chinese patent CN101120784A discloses a kind of promotion fetus and infant
The brain-care foods of brain development comprising 93~97 parts of linseed oil, 1~2 part of zinc citrate, 0.01~0.05 part of retinol, but
The product is only studied single nutritional ingredient and is acted on the brain growth of children, and multiple nutritional components synergy is directed to brain growth
Nutrition product it is relatively fewer, therefore research and develop it is a improve children's brain growth composite nutritional products be particularly important.
Summary of the invention
The purpose of the present invention is to overcome the defects in the prior art, provides a kind of tailored version for children's brain growth and faces
Bed nutrient formulation, can meet the daily nutrition demand of pregnant woman and child, and children is helped to improve cerebral nervous system, improve children's note
Recall power, promotes children's brain development.
To achieve the above object, the present invention adopts the following technical scheme:
The first purpose of the invention is to provide a kind of children's brain growth tailored version clinical nutrition formulas, which is characterized in that
Including following component and its parts by weight: 15-35 parts of protein, 2-15 parts of fat, 40-60 parts of carbohydrate, 8-12 portions of meals
Eat fiber, 0.2-1.2 parts of macroelements, 0.01-0.05 parts of microelements, 0.001-0.02 parts of liposoluble vitamins, 0.008-
0.4 part of water soluble vitamin, 4-8 parts of diet essence, 0.1-4 parts of integration of drinking and medicinal herbs ingredients and 0.05-2 parts of new resource foods.
In order to advanced optimize above-mentioned clinical nutrition formula, technical measures adopted by the present invention further include:
Further, the protein be selected from PURE WHEY, soybean protein isolate, Isin glue collagen peptide, whole milk powder,
At least one of dried whole-egg, lactoferrin, colostrum, amino acid, protein peptides.
Wherein, the amino acid is selected from L-lysine-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy
At least one of glutamine, taurine, Valine, l-Isoleucine, L-Leu;The protein peptides are selected from hydrolyzed whey
Albumen, soybean oligopeptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide
At least one of.
Further, the protein packet hydrolyzing lactoalbumin powder, soybean protein isolate and taurine.
Further, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO knot
At least one of structure rouge, DHA, EPA, ARA, phosphatide, the more specifically described fat includes safflower seed oil, walnut oil, peanut
Oil, soybean oil, Ah's glycerol, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, cupu oil, palm oil, butter, cream,
Lard, medium chain triglyceride, lecithin, Purple Perilla Seed Oil, DHA algal oil microcapsule powder, arachidonic acid oil microcapsule powder, phosphatide etc.;
More preferably Purple Perilla Seed Oil, DHA algal oil microcapsule powder, arachidonic acid oil microcapsule powder, phosphatide.
Further, the carbohydrate includes fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least one of;More preferably maltodextrin.
Further, the dietary fiber includes inulin, konjaku flour, galactooligosaccharide, oligofructose, oligomeric different malt
At least one of sugar, soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber;It is highly preferred that the dietary fiber includes water
Soluble dietary fiber and insoluble diedairy fiber, the dietary fiber include oligofructose.
Further, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, citric acid
At least one of sodium and magnesium gluconate;More preferably: calcium, wherein calcium is in calcium citrate, L- calcium lactate, calcium monohydrogen phosphate
Any one or several form additions.
Further, the microelement is selected from ferrous gluconate, potassium iodide, zinc gluconate, sodium selenite, grape
At least one of saccharic acid copper, chromium sulfate, manganese gluconate and sodium molybdate;More preferably: iron, zinc, wherein iron is with gluconic acid
Ferrous form addition, wherein zinc is added in the form of zinc gluconate.
Further, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, dimension life
Plain K1At least one of;More preferably: vitamin A, beta carotene, vitamin D3, vitamin E.
Further, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, dimension life
At least one of plain C, pantothenic acid, folic acid, niacin, choline, inositol, biotin;More preferably: vitamin B1, vitamin B2, dimension
Raw element B6, vitamin B12, vitamin C, pantothenic acid, folic acid, niacin.
Further, the diet essence is selected from cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;The cereal is selected from rice meal, millet flour, black rice flour, coixlacrymajobi powder, corn
At least one of powder, wheat germ powder, oatmeal, buckwheat;The beans is selected from peameal, mung bean flour, black bean powder, red bean
At least one of powder, soy meal;The potato is mainly made of common yam rhizome powder;The Vegetable powder be selected from carrot meal, white radish powder,
At least one of pumpkin powder, spinach powder, tomato meal, broccoli powder, balsam pear powder;The Homonemeae is selected from mushroom powder, Kelp Powder
At least one of with tremella powder;The nut-seed class is selected from least one of pumpkin seed powder and lotus nut starch;The fishes and shrimps
Class is selected from least one of salmon powder and cod meal;The poultry meat is selected from chicken meal, powdered beef, pork liver powder and pig kidney
At least one of powder;The fruits in red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder extremely
Few one kind.More preferably Kelp Powder.
Further, the integration of drinking and medicinal herbs ingredient include Radix Glycyrrhizae, fructus lycii, orange peel, Semen sesami nigrum, fructus alpiniae oxyphyllae, rhizoma polygonati, oyster,
At least one of Poria cocos, Chinese yam, jujube, arillus longan;It more preferably include Radix Glycyrrhizae, fructus lycii, orange peel, Semen sesami nigrum, fructus alpiniae oxyphyllae, Huang
Essence, oyster, Poria cocos, Chinese yam, specially 0.02~1 portion of Radix Glycyrrhizae, 0.02~1 portion of fructus lycii, 0.02~1 part of orange peel, 0.02~1 part
Semen sesami nigrum, 0.02~1 part of fructus alpiniae oxyphyllae, 0.02~1 part of rhizoma polygonati, 0.02~1 portion of oyster, 0.02~1 part of Poria cocos, 0.02~1 part of mountain
Medicine.
Further, it is few to be selected from first milk basic protein, hydrolysis yolk powder, γ-aminobutyric acid, shell for the new resource food
Sugar, eucommia Bark male flower, bamboo-leaves flavones, casein phosphopeptide, fish oil, avenabeta glucosan, Oligomeric manna sugar, Rosa roxburghii Tratt, yeast β-Portugal
At least one of glycan, newborn mineral salt, pueraria root powder, Rosa roxburghii Tratt, xylo-oligosaccharide;More preferably γ-aminobutyric acid, oligomeric sweet dew
Sugar.
Further, above-mentioned nutrient formulation may also include nucleotide, be specially 5 ' monophosphate cytidines.
Further, children's brain growth tailored version clinic includes: maltodextrin, hydrolyzing lactoalbumin powder, purple perilla seed
Oil, oligofructose, soybean protein isolate, resistant dextrin, DHA algal oil microcapsule powder, arachidonic acid oil microcapsule powder, Kelp Powder,
Radix Glycyrrhizae, fructus lycii, orange peel, Semen sesami nigrum, fructus alpiniae oxyphyllae, rhizoma polygonati, oyster, Poria cocos, Chinese yam, Oligomeric manna sugar, γ-aminobutyric acid, calcium,
Iron, zinc, vitamin A, beta carotene, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12、
Vitamin C, niacin, folic acid, pantothenic acid, taurine, phosphatide.
Further, above-mentioned nutrient formulation may also include enzymolysis pearl powder, black bone chicken powder, peony oil, choline and ganglioside
Rouge.
Pearl contains the important substance for largely having magical effect to human body, a variety of amino acid and various trace elements,
Indispensable amino acid starting material when synthesizing a variety of important good proteins in baby's growth course can be provided, fetal nerve is promoted
System and cell development allow the brain of fetus to obtain innate advantage, while safeguarding the visual function of pregnant fetus, after enzymolysis processing
Pearl powder is fully dissolved in water, and nutritional ingredient can be fully retained, but pearl calcium content is high, should add in right amount.Contain in Gallus domesticlus brisson
There are DHA and EPA, the serial polyunsaturated fatty acid of the ω -3 such as DHA and EPA can promote brain development.It is unsaturated in peony oil
Fatty acid is up to 80% or more, has good facilitation to infant's brain development, highly increases intelligence, and the dimension contained by it
Raw element B3The metabolism of various tissues is maintained for infant, is promoted neoblastic growth and maturation, is baby's brain development
Critical nutrients.Choline is the important source material for synthesizing acetylcholine, and acetylcholine is the important nerve for participating in memory and being formed
Mediator, it can help to transmit information between nervous centralis, be one of necessary materials of intelligency activities such as human thinking, memory.Nerve
Saving glycosides rouge helps nervous system development and information transmission, including neuron to generate dendroid, helps the efficiency for improving connection, newborn
Youngster has 100,000,000,000 nerves not connected, and the nerve connection of high speed occurs to need a large amount of gangliosides, gangliosides
The effect of be reinforce learning ability and maintain memory, promote brain growth.
Further, above-mentioned nutrient formulation may also include probiotic micro, and the probiotic micro is selected from intestines
At least one of road fungal component bacteroides fragilis, Bifidobacterium, lactobacillus acidophilus, Lactobacillus rhamnosus.Probiotics is a kind of
There is the active microorganism beneficial to host biobalance, biological barrier, biology to take oxygen, immunity effect, nutrition and substance, energy by force
The functions such as the exchange between amount and information.Infantile period is the critical period that normal flora is established, and good flora foundation can be supported
Imperial pathogenic microorganism invasion.The addition of probiotics can preferably protect enteron aisle, enhancing intestinal immunity, so that it is guaranteed that each nutrition
The absorption of substance.
A second object of the present invention is to provide a kind of preparation sides of above-mentioned children's brain growth tailored version clinical nutrition formula
Method method comprising following steps:
Step 1) prepares fat powder, liposoluble vitamin powder and water soluble vitamin powder using micro-capsule embedding techniques
End;
Step 2) mentioned using crushing, alcohol extracting, water, be spray-dried and sifting step prepares integration of drinking and medicinal herbs component powders;
Step 3) is smart by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, microelement, diet
China and new resource food are prepared into the powder that partial size is 150~250 μm respectively, if necessary can be preparatory by above-mentioned raw materials
It carries out baking processing;
Step 4) is by step 1)~3) powder of preparation sterilize after mixing it is spare;
The mixed powder of step 4) is prepared into nutrient powder, nutrition emulsion, capsule according to conventional technical means by step 5)
At least one of agent, tablet, pill or oral solution;
Wherein, step 1) -3) sequence can mutually replace.
Finally, the present invention relates to a kind of products prepared by above-mentioned children's brain growth tailored version clinical nutrition formula, including
Nutrient powder, nutrition emulsion, capsule, tablet, pill, oral solution etc..
In the above preparation method, wherein the raw material of the integration of drinking and medicinal herbs ingredient crushed, alcohol extracting concentration, water concentrate
Contracting, and concentrate is subjected to spray drying, integration of drinking and medicinal herbs component powders are made;Wherein, the vitamin and fat are respectively by micro-
Encapsulated processing is prepared into vitamin powder and fat powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows: using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, and 7~8 times of 30~40% second that weight is raw material weight are added
Alcohol is impregnated, is extracted 3 times, is merged alcohol extract and is concentrated into no alcohol taste;After the raw medicine dregs of a decoction fling to ethyl alcohol, it is original that weight, which is added,
3~4 times of water of material weight is impregnated, and carries out 15~20min of decoction to soak, filtering removal raw material leaves and takes decoction
Liquid;Alcohol extract and decoction liquor after merging concentration, and it is spray-dried, it is same finally to prepare medicine food with 60~80 meshes point
Derived components powder.
Preferably, specific step is as follows for the microencapsulation processing of the vitamin: 1) using liposoluble vitamin as core
Material selects sodium carboxymethylcellulose, gelatin, carragheen, xanthan gum, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One of powder, emulsifier, stabilizer are a variety of as wall material, and high-pressure homogeneous emulsification is spraying instantaneous dry, with 60~80 meshes
Divide and prepares liposoluble vitamin powder;2) using water soluble vitamin as core material, sodium carboxymethylcellulose, gelatin, OK a karaoke club are selected
Glue, xanthan gum, Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, chrysanthemum
One of powder, PURE WHEY, oligoisomaltose, soybean fiber, lactose, candy sugar powder, emulsifier, stabilizer or a variety of works
For wall material, it is uniformly mixed, it is spraying instantaneous dry, water soluble vitamin powder is prepared with 60~80 meshes point.
Preferably, the specific implementation step of the micro-capsule embedding techniques of the fat is as follows: by fat, emulsifier, wall material with
Water mixed dissolution prepares emulsion;After above-mentioned emulsion is stirred, emulsifying homogeneous processing is carried out, is then done by spraying
Dry, screening prepares fat powder, and fat powder is compared with conventional grease, and dispersibility, water solubility, emulsibility, inoxidizability are all
It improves a lot;Wherein, the emulsifier be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
Sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin, monoglyceride, one in Tween 80
Kind is a variety of;The wall material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthan gum, Arabic gum, maltodextrin, rouge egg
White, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean
One of fiber, lactose, candy sugar powder, emulsifier, stabilizer are a variety of.
The present invention also provides a kind of preparation methods of above-mentioned children's brain growth tailored version clinical nutrition formula, are wet process work
Skill includes the following steps:
Step 1) prepare the protein containing predetermined weight number, fat, carbohydrate, dietary fiber, macroelement,
Microelement, vitamin, diet essence, integration of drinking and medicinal herbs ingredient and new resource food raw material pressed in the water of predetermined amount
It according to the physical behavior of raw material, successively adds according to sequencing, is stirred while addition, the mixing cream of raw material is made
Liquid;
The mixed emulsion temperature that step 1) obtains is maintained at 40-50 DEG C by step 2), and adjustment homogenization pressure protects it always
It holds between 10-18Mpa, emulsifying homogeneous is carried out to mixed emulsion, is then placed emulsion in evaporator, with preset technology
Parameter is concentrated, and is sterilized at 85-88 DEG C, and concentrate is obtained;
The concentrate that step 2) obtains is spray-dried by step 3), is crossed 60~80 meshes, is prepared into powder;Using upper
It states powder and is prepared at least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution.
Using including Radix Glycyrrhizae, fructus lycii, orange peel, Semen sesami nigrum, fructus alpiniae oxyphyllae, rhizoma polygonati, oyster, Poria cocos, Chinese yam in the present invention;Its
In, Radix Glycyrrhizae can be pleasant, promotes giving vent to for internal heat, helps the stabilization of mood, also there is certain relaxation effect, energy for spleen deficiency
Enough help tonifying spleen;Fructus lycii can nourishing liver and kidney, benefiting shrewd head and blood-nourishing, enhance human immunity;Orange peel has conditioning digestion
System enhances functions of intestines and stomach, and cholagogue is aid digestion, reduces for spleen deficiency diet, indigestion, receives to intestines caused by anti-acetylcholine
Intestinal tube spasmodic contraction caused by contracting and antagonism pilocarpinum and barium chloride;Semen sesami nigrum contains there are many essential amino acid,
It can increase the metabolic function of human body, also have effects that supplement brain intelligence, can promote brain development;The warm spleen of fructus alpiniae oxyphyllae energy stops
It rushes down, appetite-stimulating and indigestion-relieving, enhancing children digestion, absorption function, balances interior environment, improve immune function;Rhizoma polygonati can supplementing the kidney to control the nocturnal, fill
It is full of muscle, improves body immunity;Oyster taurine rich in has apparent hepatoprotective and cholagogic effects, and micro- containing enriching
Secondary element and glycogen, and be conducive to promote the growth and development of fetus;Poria cocos can increase body's immunity, diuresis clearing damp, and ease constipation is led to
Just, improve and digest and assimilate, transportation capabilities of the enhancing human body to food;Chinese yam can improve body's immunity, contain starch, albumen
The various nutrients such as matter, mucilaginous substance, choline and lecithin rich in, help to improve the memory of the brain of people.
Compared with prior art, the invention has the following advantages:
In children's brain growth tailored version clinical nutrition formula of the present invention, perilla herb oil, n-3 PUFAs therein are added
The building of film is participated in, the expression of gene is adjusted and effect that is anti-inflammatory and inhibiting Apoptosis is played by its metabolite
Deng.The mechanism of action that n-3PUFAs influences brain function initially focuses mostly in the influence to brain membranous structure, PUFAs in phosphatide
The mobility for changing changeable film, influences the transmitting of the neurotransmitters such as function, dopamine and the serotonergic of membrane receptor, adjusting film
Binding protein, such as the activity of Na+/K+ dependence ATP enzyme.Change to provide a high-intensitive substance for brain by these
The transduction environment of exchange and signal, plays an important role to the stability of cell.
Children's brain growth tailored version clinical nutrition formula supplement addition iron, zinc and vitamin B of the present invention1.Iron point
Be distributed in entire brain tissue, but be unevenly distributed, the most abundant part of iron content is the core group of extrapyramidal system, as Basal ganglia, globus pallidus,
The some regions of black substance, rubrum, followed by cerebellum and brain.The study found that main siderophore is oligodendroglia in brain tissue
Cell, the cell major function are to participate in central nervous system myelin to be formed, and iron deficiency makes myelin formation be obstructed in brain growth.It is few prominent
The variation of spongiocyte quantity will have a direct impact on utilization of the intracerebral neuron to iron, therefore think that oligodendroglia is brain tissue
The adjusting body of iron balance.Zinc is the important composition ingredient of brain, the content of zinc highest in akrencephalon and cerebral cortex grey matter in brain.It lacks
Vivo acid oxidation process increases when zinc, and histone synthesis is reduced, and growth and development is affected.Vitamin B1That is thiamine
It plays an important role in body carbohydrate metabolism, if lacking thiamine, metabolic process will slack-off or complete interruption.
Children's brain growth tailored version clinical nutrition formula of the present invention also adds taurine, can promote brain cell
The synthesis of DNA, RNA, the phosphatidylethanolamine content and brain cell for increasing film are to the utilization rate of protein, to promote brain cell
The especially development of hippocampal cell structure and function;
γ-aminobutyric acid is added, the decarboxylic reaction of glutamic acid can be inhibited, is reacted with α-ketoglutaric acid and generates glutamic acid,
Reduce blood ammonia, more glutamic acid and ammonia are combined into urea, excrete, and lower ammonia poison, improve hepatic and renal function.It can be improved
The activity of glucose phosphate esterase keeps brain cell activity vigorous, promotes brain cell tissue metabolism, improves nervous function;
Phosphatide is added, total phosphorus lipid is related with the generation of cell membrane, and contains choline, is a kind of help human body manufacture brain
The important composition of neural message transmitter (acetylcholine).Lecithin abundant is absorbed, the development of brains is helped, it is living to improve brain
Dynamic efficiency.
The present invention is by selecting reasonable basal nutrient element, using the proportion of general equilibrium, while adding with brain tonic benefit
The specific nutrients such as the integration of drinking and medicinal herbs ingredient of intelligence, stomach strengthening and digestion promoting, strengthen immunity and other effects, new resource food, and adjust it and match
Than carrying out compatibility synergy with basal nutrient element, the daily required necessary nutritional ingredient of children's brain growth, and the nutrition are supplemented comprehensively
Formula is easier the effect of being digested and assimilated by pregnant woman and child, giving full play to its each component, effectively guarantees children's brain growth institute
Necessary nutrient, guarantee pregnant woman and infant's grows up healthy and sound in all respects.
Specific embodiment
The present invention provides a kind of children's brain growth tailored version clinical nutrition formula, including following component and its parts by weight:
15-35 parts of protein, 2-15 parts of fat, 40-60 parts of carbohydrate, 8-12 parts of dietary fibers, 0.2-1.2 parts of macroelements,
0.01-0.05 parts of microelements, 0.001-0.02 parts of liposoluble vitamins, 0.008-0.4 parts of water soluble vitamins, 4-8 portions of meals
Eat essence, 0.1-4 parts of integration of drinking and medicinal herbs ingredients and 0.05-2 parts of new resource foods.
With reference to embodiment, the specific embodiment of the present invention is further described.Following embodiment is only used for more
Add and clearly demonstrate technical solution of the present invention, and not intended to limit the protection scope of the present invention.
Embodiment 1
Children's brain growth tailored version clinical nutrition formula of the present invention includes maltodextrin 45g, hydrolyzing lactoalbumin
Powder 20g, Purple Perilla Seed Oil 6g, oligofructose 6g, soybean protein isolate 6g, resistant dextrin 4g, DHA algae oil microcapsule powder 2g, peanut four
Olefin(e) acid grease microcapsule powder 2g, Kelp Powder 6g, Radix Glycyrrhizae 0.4g, fructus lycii 0.4g, orange peel 0.6g, Semen sesami nigrum 0.6g, fructus alpiniae oxyphyllae 0.4g, Huang
Smart 0.4g, oyster 0.6g, Poria cocos 0.6g, Chinese yam 0.6g, Oligomeric manna sugar 0.4g, γ-aminobutyric acid 0.4g, calcium 0.42g, iron
0.018g, zinc 0.016g, vitamin A 0.001g, beta carotene 0.002g, vitamin D30.0000015g, vitamin E
0.000016g, vitamin B10.002g, vitamin B20.002g, vitamin B60.002g, vitamin B12 0.000004g、
Vitamin C 0.18g, niacin 0.02g, folic acid 0.0006g, pantothenic acid 0.006g, taurine 0.12g, phosphatidase 0 .4g.
Embodiment 2
Children's brain growth tailored version clinical nutrition formula of the present invention includes maltodextrin 51.6g, hydrolyzed whey egg
White powder 20g, Purple Perilla Seed Oil 3g, oligofructose 6g, soybean protein isolate 6g, resistant dextrin 4g, DHA algae oil microcapsule powder 0.2g, flower
Raw tetraene acid lipid microcapsule powder 0.2g, Kelp Powder 6g, Radix Glycyrrhizae 0.4g, fructus lycii 0.4g, orange peel 0.6g, Semen sesami nigrum 0.6g, fructus alpiniae oxyphyllae
0.4g, rhizoma polygonati 0.4g, oyster 0.6g, Poria cocos 0.6g, Chinese yam 0.6g, Oligomeric manna sugar 0.4g, γ-aminobutyric acid 0.4g, calcium
0.42g, iron 0.018g, zinc 0.016g, vitamin A 0.001g, beta carotene 0.002g, vitamin D3 0.0000015g、
Vitamin E 0.000016g, vitamin B10.002g, vitamin B20.002g, vitamin B60.002g, vitamin B12
0.000004g, vitamin C 0.18g, niacin 0.02g, folic acid 0.0006g, pantothenic acid 0.006g, taurine 0.12g, phosphatide
0.4g。
Embodiment 3
Children's brain growth tailored version clinical nutrition formula of the present invention includes maltodextrin 51.6g, hydrolyzed whey egg
White powder 20g, Purple Perilla Seed Oil 3g, oligofructose 6g, soybean protein isolate 6g, resistant dextrin 4g, DHA algae oil microcapsule powder 0.2g, flower
Raw tetraene acid lipid microcapsule powder 0.2g, Kelp Powder 6g, Radix Glycyrrhizae 0.04g, fructus lycii 0.04g, orange peel 0.06g, Semen sesami nigrum 0.06g, benefit
Intelligence benevolence 0.04g, rhizoma polygonati 0.04g, oyster 0.06g, Poria cocos 0.06g, Chinese yam 0.06g, Oligomeric manna sugar 0.4g, γ-aminobutyric acid
0.4g, calcium 0.42g, iron 0.018g, zinc 0.016g, vitamin A 0.001g, beta carotene 0.002g, vitamin D3
0.0000015g, vitamin E 0.000016g, vitamin B10.002g, vitamin B20.002g, vitamin B6 0.002g、
Vitamin B120.000004g, vitamin C 0.18g, niacin 0.02g, folic acid 0.0006g, pantothenic acid 0.006g, taurine
0.12g, phosphatidase 0 .4g.
Embodiment 4
Children's brain growth tailored version clinical nutrition formula of the present invention includes maltodextrin 51.6g, hydrolyzed whey egg
White powder 20g, Purple Perilla Seed Oil 3g, oligofructose 6g, soybean protein isolate 6g, resistant dextrin 4g, DHA algae oil microcapsule powder 0.2g, flower
Raw tetraene acid lipid microcapsule powder 0.2g, Kelp Powder 6g, Radix Glycyrrhizae 0.04g, fructus lycii 0.04g, orange peel 0.06g, Semen sesami nigrum 0.06g, benefit
Intelligence benevolence 0.04g, rhizoma polygonati 0.04g, oyster 0.06g, Poria cocos 0.06g, Chinese yam 0.06g, Oligomeric manna sugar 0.04g, γ-aminobutyric acid
0:04g, calcium 0.42g, iron 0.018g, zinc 0.016g, vitamin A 0.001g, beta carotene 0.002g, vitamin D3
0.0000015g, vitamin E 0.000016g, vitamin B10.002g, vitamin B20.002g, vitamin B6 0.002g、
Vitamin B120.000004g, vitamin C 0.18g, niacin 0.02g, folic acid 0.0006g, pantothenic acid 0.006g, taurine
0.12g, phosphatidase 0 .4g.
Embodiment 5
A kind of children's brain growth tailored version clinical nutrition formula as described in Example 1 the preparation method is as follows:
1) powdered oil (powder fat) is prepared:
A) it prepares wall material aqueous solution: taking 8 grams of maltodextrin, 11 grams of whole-fat milk powder, dietary fiber 2 grams of (resistant dextrin), chrysanthemums
0.5 gram of powder, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, 0.2 gram of Arabic gum, 0.5 gram of lactose,
2 grams of candy sugar powder, 50 milliliters of water stir evenly (have ready conditions and heat while stirring to 60 DEG C, keep 30 minutes after be cooled to room temperature).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (Purple Perilla Seed Oil in 7.79 milliliters of greases monoglyceride
5.63 milliliters, 1.88 milliliters of DHA algal oil microcapsule powder, 1.88 milliliters of arachidonic acid oil microcapsule powder .38 milliliters of phosphatidase 0).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1 gram (total solid concentration be 0.2%) into after mixed solution, is settled to water
200 milliliters (total solid concentration be 25%), high speed dispersion 2 minutes under 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous 3 times (every time 5 minutes), homogeneous emulsion is made.
G) emulsion obtained is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C.Collect powder
Grease (powder fat);
2) integration of drinking and medicinal herbs component powders are prepared: being crushed, will be crushed using raw material of the pulverizer to predetermined weight number
Raw material be placed in container, crushed using raw material of the pulverizer to predetermined weight number, the raw material of crushing be placed in container
In, be added weight be raw material weight 3~8 times of water, carry out immersion 3~4 hours, then to soak carry out decoction 30~
60min, filtering removal raw material, leaves and takes decoction liquor, is spray-dried to decoction liquor, prepares integration of drinking and medicinal herbs with 60~80 meshes point
Component powders;
3) prepare vitamin powder: using the liposoluble vitamin of predetermined weight number as core material, select carragheen, I
Primary glue carries out 2 emulsifying homogeneous processing as wall material under high pressure, and the emulsifying homogeneous time is 10~15min, is then sprayed
Mist is instantaneously dried, and prepares liposoluble vitamin powder with 60~80 meshes point;The water soluble vitamin of predetermined weight number is made
For core material, selects maltodextrin, lipoprotein as wall material, be uniformly mixed, it is spraying instantaneous dry, water is prepared with 60~80 meshes point
Soluble vitamin powder;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, microelement, diet essence with
And new resource food is prepared into the powder that partial size is 150~250 μm respectively;(step 1) -4) sequence can mutually replace)
5) by step 1) -4) powder of preparation sequentially adds the mixing machines of cone-type mixer or other forms and is uniformly mixed system
Formula mixture is obtained, it is spare after sterilization processing;
6) according to conventional technical means by the formula mixture in step 5) be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral solution.
In step 6), optionally increase suitable food thickening agent, food additives and related dosage form auxiliary material.
The food thickening agent is guar gum, in xanthan gum, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
At least one, the food additives be at least one of Aspartame, edible essence fragrance, brown sugar;More preferable OK a karaoke club
Glue, Arabic gum, guar gum, Aspartame, edible essence fragrance.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder explosion.
It can be prepared into the classifications such as powdery, graininess, capsule shape, tablet shape, beverage according to the formula.
Verify embodiment 1
It chooses rat stochastic averagina and is assigned to experimental group, contrast groups and untreated fish group.
Experimental group 1: feed the feed of the nutrition powder prepared containing embodiment 1 (100g feed adds 5g nutrition powder);
Experimental group 2: the nutrition powder prepared containing embodiment 1 and Lactobacillus rhamnosus, Bifidobacterium, enzymatic hydrolysis treasure are fed
Pearl powder, black bone chicken powder, peony oil, choline and gangliosides feed (100g feed adds 5g nutrition powder), wherein relative to reality
Apply the nutrition powder of the preparation of example 1, Lactobacillus rhamnosus, Bifidobacterium, enzymolysis pearl powder, black bone chicken powder, peony oil, choline and nerve
The additive amount for saving glycosides rouge is 0.2g.
Contrast groups: feeding the feeds of the brain-care foods prepared containing CN101120784A embodiment 1, (100g feed adds
1.5g brain-care foods);
Control group: normal diet is fed.
After nursing in 30 days, during nursing, the non-abnormal symptom of each rat and sign, also without death.Total food
Utilization rate equal no significant difference compared with the control group;Each group content of hemoglobin, red blood cell count(RBC), white blood cell count(WBC) and classification are equal
In the normal range, for every biochemical indicator in the normal range, each main organs gross anatomy detection does not find obvious disease
Become.Demonstrating nutrient formulation of the present invention above will not influence normal growth and the development of rat, for that can eat safely
Product.
Verify embodiment 2
100 progress clinical observations of children's atelencephalia patient are screened, and are randomly divided into two groups, experimental group 1, experimental group
2 and control group (every group of 50 people).Experimental group 1 use the resulting nutrition product of the present embodiment 1, experimental group 2 using embodiment 1 with
And Lactobacillus rhamnosus, Bifidobacterium, enzymolysis pearl powder, black bone chicken powder, peony oil, choline and the resulting nutrient solution of gangliosides
Product, the instructions of taking of experimental group 1 and 2: oral, 1 years old or less each 10ml, 1~6 years old each 20ml, 7~14 years old every time
30ml, 2 times a day.Control group uses drug (such as the cerebroganglion glycosides rouge injection, brain egg of conventional therapy children atelencephalia
White hydrolysate, mouse nerve growth factor, oxiracetam injection etc.).
Curative effect situation criterion: effective: after being taken 30 days, clinical symptoms and sign disappear substantially;It improves: through taking
After 30 days, clinical symptoms and sign are clearly better;Invalid: after being taken 30 days, clinical symptoms and sign slightly improvement or nothing change
It is kind.It always effectively include effective and improvement.The results are shown in Table 1:
As seen from the above table, compared with control group (existing preparation), the present invention in by embodiment prepare nutrient formulation for
Children atelencephalia patient has more excellent curative effect, this shows each component combination and compatibility in the nutrient formulation of the invention used
It uses, produces synergistic beneficial effect.
As can be seen from the above embodiments, children's brain growth tailored version clinical nutrition compound basis pregnant woman of the present invention and small
The physilogical characteristics of youngster design, and on the basis of guaranteeing protein, fat, carbohydrate, dietary fiber, supplement many human body institutes
Need macroelement and microelement, and add have brain tonic and intelligence development, stomach strengthening and digestion promoting, strong immunity and other effects integration of drinking and medicinal herbs at
Point, the specific nutrients such as new resource food effectively guarantee children's brain growth so that the formula nutritional is balanced, guarantee pregnant woman and
Infant's grows up healthy and sound in all respects.
Specific embodiments of the present invention are described in detail above, but it is only used as example, the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, the equivalent modifications and replace that any couple of present invention carries out
In generation, is also all among scope of the invention.Therefore, without departing from the spirit and scope of the invention made by equal transformation and repair
Change, all should be contained within the scope of the invention.
Claims (10)
1. a kind of children's brain growth tailored version clinical nutrition formula, which is characterized in that including following component and its parts by weight:
15-35 parts of protein, 2-15 parts of fat, 40-60 parts of carbohydrate, 8-12 parts of dietary fibers, 0.2-1.2 parts of macroelements,
0.01-0.05 parts of microelements, 0.001-0.02 parts of liposoluble vitamins, 0.008-0.4 parts of water soluble vitamins, 4-8 portions of meals
Eat essence, 0.1-4 parts of integration of drinking and medicinal herbs ingredients and 0.05-2 parts of new resource foods;
Wherein, the integration of drinking and medicinal herbs ingredient includes Radix Glycyrrhizae, fructus lycii, orange peel, Semen sesami nigrum, fructus alpiniae oxyphyllae, rhizoma polygonati, oyster, Poria cocos, mountain
Medicine;The fat includes Purple Perilla Seed Oil, DHA algal oil microcapsule powder, arachidonic acid oil microcapsule powder, phosphatide;The new resources food
Product include γ-aminobutyric acid, Oligomeric manna sugar.
2. a kind of children's brain growth tailored version clinical nutrition formula according to claim 1, which is characterized in that the carbon water
Compound includes at least one of fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch.
3. a kind of children's brain growth tailored version clinical nutrition formula according to claim 1, which is characterized in that the albumen
Matter includes amino acid, and the amino acid includes taurine, and the parts by weight of the taurine are 0.1~0.3 part.
4. a kind of children's brain growth tailored version clinical nutrition formula according to claim 1, which is characterized in that the medicine food
It include 0.02-1 portions of Radix Glycyrrhizaes, 0.02-1 portions of fructus lyciis, 0.02-1 parts of orange peels, 0.02-1 portions of Semen sesami nigrums, 0.02-1 parts of benefits with derived components
Intelligence benevolence, 0.02-1 part rhizoma polygonati, 0.02-1 portions of oysters, 0.02-1 parts of Poria cocos, 0.02-1 portions of Chinese yams.
5. a kind of children's brain growth tailored version clinical nutrition formula according to claim 1, which is characterized in that the phosphatide
Parts by weight be 0.2~1 part.
6. a kind of children's brain growth tailored version clinical nutrition formula according to claim 1, which is characterized in that the nutrition
Formula includes maltodextrin, hydrolyzing lactoalbumin powder, Purple Perilla Seed Oil, oligofructose, soybean protein isolate, resistant dextrin, DHA algal
Oily microcapsule powder, arachidonic acid oil microcapsule powder, Kelp Powder, Radix Glycyrrhizae, fructus lycii, orange peel, Semen sesami nigrum, fructus alpiniae oxyphyllae, rhizoma polygonati, oyster,
Poria cocos, Chinese yam, Oligomeric manna sugar, γ-aminobutyric acid, calcium, iron, zinc, vitamin A, beta carotene, vitamin D3, vitamin
E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, niacin, folic acid, pantothenic acid, taurine, phosphatide.
7. a kind of children's brain growth tailored version clinical nutrition formula according to claim 6, which is characterized in that the nutrition
Formula further includes enzymolysis pearl powder, black bone chicken powder, peony oil, choline and gangliosides.
8. a kind of children's brain growth tailored version clinical nutrition formula according to claim 6, which is characterized in that the nutrition
Formula further includes probiotic micro, the probiotic micro be selected from commensal gut bacterium bacteroides fragilis, Bifidobacterium,
At least one of lactobacillus acidophilus, Lactobacillus rhamnosus.
9. a kind of preparation method of such as children's brain growth tailored version clinical nutrition formula according to any one of claims 1 to 8,
It is characterized by comprising the following steps:
The preparation of micro-capsule embedding techniques is respectively adopted simultaneously in the fat, liposoluble vitamin, water soluble vitamin of step (1) predetermined weight
It crosses 60~80 meshes and powder is made;
The integration of drinking and medicinal herbs ingredient of step (2) predetermined weight is mentioned by crushing, alcohol extracting, water, is spray-dried and cross 60-80 mesh and is made
Powder;
Remaining component of step (3) predetermined weight is prepared into the powder that partial size is 150~250 μm respectively;
Step (4) sterilizes powder prepared by step (1)~(3) spare after mixing;
Direct-edible pharmaceutical formulation is made in step (4) mixed powder by step (5);
Wherein, step (1)~(3) sequence can be replaced mutually;The pharmaceutical formulation include nutrient powder, nutrition emulsion, capsule,
Tablet, pill, oral solution.
10. the preparation method of children's brain growth tailored version clinical nutrition formula described according to claim 1~any one of 8,
It is characterized by comprising the following steps:
Step 1) prepares the protein containing predetermined weight number and amino acid, fat, carbohydrate, dietary fiber, constant
Element, microelement, vitamin, integration of drinking and medicinal herbs ingredient and new resource food raw material powder pressed in the water of predetermined amount
It according to the physical behavior of raw material, successively adds according to sequencing, is stirred while addition, the mixing cream of raw material is made
Liquid;
The mixed emulsion that step 2) obtains step 1) carries out emulsifying homogeneous, concentrating sterilizing, obtains concentrate;
The concentrate that step 2) obtains is spray-dried by step 3), and sieving is prepared into powder, and above-mentioned powder is prepared into
At least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910267322.5A CN109965271A (en) | 2019-04-03 | 2019-04-03 | A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910267322.5A CN109965271A (en) | 2019-04-03 | 2019-04-03 | A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109965271A true CN109965271A (en) | 2019-07-05 |
Family
ID=67082805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910267322.5A Withdrawn CN109965271A (en) | 2019-04-03 | 2019-04-03 | A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109965271A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113908258A (en) * | 2021-11-11 | 2022-01-11 | 贵州贝斯生物科技有限公司 | Preparation method and preparation device of ingestible ganglioside complementary peptide |
CN115039876A (en) * | 2022-05-20 | 2022-09-13 | 南通大学 | A functional food for preventing and/or treating leukodystrophy |
CN117397810A (en) * | 2023-11-07 | 2024-01-16 | 广东金海康医学营养品股份有限公司 | DHA algae oil special dietary drink and preparation method thereof |
-
2019
- 2019-04-03 CN CN201910267322.5A patent/CN109965271A/en not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113908258A (en) * | 2021-11-11 | 2022-01-11 | 贵州贝斯生物科技有限公司 | Preparation method and preparation device of ingestible ganglioside complementary peptide |
CN113908258B (en) * | 2021-11-11 | 2023-10-20 | 贵州贝斯生物科技有限公司 | Preparation method and preparation device of orally taken ganglioside supplement peptide |
CN115039876A (en) * | 2022-05-20 | 2022-09-13 | 南通大学 | A functional food for preventing and/or treating leukodystrophy |
CN117397810A (en) * | 2023-11-07 | 2024-01-16 | 广东金海康医学营养品股份有限公司 | DHA algae oil special dietary drink and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109645320A (en) | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN102429307A (en) | Low-calorie and total-nutrient beverage and preparation method thereof | |
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN109965271A (en) | A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN110301629A (en) | A kind of full nutrient solid beverage of tumor patient and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN105432792A (en) | Basic nutrition milk powder for preschool children, nutrition milk powder suit and preparation methods | |
CN109965273A (en) | A kind of children's hyperkinetic syndrome tailored version clinical nutrition formula and preparation method thereof | |
CN109156530A (en) | A kind of diatery supplement nutrition packet and its production technology | |
CN109170916A (en) | One kind keeps fit and healthy food compositions and preparation method thereof | |
CN109965272A (en) | A kind of children's lead discharging tailored version clinical nutrition formula and preparation method thereof | |
CN100479671C (en) | Method for preparing sour milk containing composite micron pollen pini and konjak for reducing-weight and lowering-blood sugar | |
CN108095075A (en) | Miscarriage women tailored version clinical nutrition formula and preparation method thereof | |
CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
CN113729211A (en) | Composition and preparation method and application thereof | |
CN100469253C (en) | Method for preparing tumor mutation-resisting yoghourt with micron ash tree pollen, pine pollen, bee pollen and ganoderma lucidum spore powder | |
CN110623073A (en) | Formula milk powder beneficial to body height and preparation method thereof | |
CN109845826A (en) | A kind of infant milk powder for simulating breast milk fatty acids structure and composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190705 |